| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/2008 | WO2008007103A1 Furo [3, 2-b] pyrrol derivatives |
| 01/17/2008 | WO2008007099A1 A pharmaceutical formulation comprising a beta2-selective adrenorezeptor agonist and / or glucocorticoid and method for the preparation thereof |
| 01/17/2008 | WO2008007081A1 Short-acting benzodiazepine salts and their polymorphic forms |
| 01/17/2008 | WO2008007071A1 Short-acting benzodiazepine salts and their polymorphic forms |
| 01/17/2008 | WO2008007027A1 New 5-thioxylopyranose derivatives |
| 01/17/2008 | WO2008006979A2 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | WO2008006974A2 Use of histamine h4 receptor ligands to protect haematopoietic progenitors against the haematological toxicity of chemotherapeutic agents |
| 01/17/2008 | WO2008006918A1 Use of flumazenil in the production of a medicament for the treatment of depressive disorders |
| 01/17/2008 | WO2008006895A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 01/17/2008 | WO2008006888A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 01/17/2008 | WO2008006848A1 Composition comprising a retinoid and benzoyl peroxide |
| 01/17/2008 | WO2008006838A1 Use of flibanserin for the treatment of sexual disorders in females |
| 01/17/2008 | WO2008006828A1 Zilpaterol enantiomer compositions and methods of making and using such compositions |
| 01/17/2008 | WO2008006824A1 Novel tyrosinase inhibitors, their process of preparation and their use in human medicine and in cosmetics |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006794A1 Indole compounds having affinity to the ep1 receptor |
| 01/17/2008 | WO2008006793A1 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006716A2 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | WO2008006715A2 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | WO2008006714A2 Improvements relating to biocidal compositions |
| 01/17/2008 | WO2008006713A2 Improvements relating to anti-parasitic compositions |
| 01/17/2008 | WO2008006703A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006663A1 2-arylindole derivatives as npges-i inhibitors |
| 01/17/2008 | WO2008006648A1 Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials |
| 01/17/2008 | WO2008006627A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | WO2008006626A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiinflammatory agents |
| 01/17/2008 | WO2008006625A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/17/2008 | WO2008006607A2 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 01/17/2008 | WO2008006589A2 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006582A1 Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| 01/17/2008 | WO2008006581A2 Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders |
| 01/17/2008 | WO2008006563A1 Purine derivatives as a2a agonists |
| 01/17/2008 | WO2008006561A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/17/2008 | WO2008006547A2 Pyrrolopyrimidines for pharmaceutical compositions |
| 01/17/2008 | WO2008006528A2 Pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | WO2008006511A2 Use of fosfluridine tidoxil (ft) for the treatment of intraepithelial proliferative diseases |
| 01/17/2008 | WO2008006509A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/17/2008 | WO2008006480A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/17/2008 | WO2008006479A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 01/17/2008 | WO2008006432A1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 01/17/2008 | WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 01/17/2008 | WO2008006369A1 Adenosine receptor antagonists |
| 01/17/2008 | WO2008006319A1 BIBENZIMIDAZOLE DERIVATIVES HAVING PPARγ AGONIST ACTIVITY AND THEIR USES |
| 01/17/2008 | WO2008006298A1 Novel crystal form of doripenem, preparation method and uses thereof |
| 01/17/2008 | WO2008006295A1 New optical active phenylethanol amines and preparing method thereof |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2008006286A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE |
| 01/17/2008 | WO2008006285A1 Stabilization compositions for cysteamine and its hydrochloride and process methods related |
| 01/17/2008 | WO2008006284A1 Use of calcium salt of polyenoic acid in medical and cosmetic field |
| 01/17/2008 | WO2008006276A1 THE SMALL MOLECULE INHIBITOR WHICH CAN INHIBIT THE AβPOLYPEPTIDE FIBROSIS OF ALZHEIMER'S DISEASE, THEIR PREPAREATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF |
| 01/17/2008 | WO2008006257A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 01/17/2008 | WO2008006226A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | WO2008006224A1 Medicagenic acid saponin and uses thereof |
| 01/17/2008 | WO2008006216A1 Anti-inflammatory and cytoprotectant chronotherapy |
| 01/17/2008 | WO2008006202A1 Fatty acid desaturases and uses thereof |
| 01/17/2008 | WO2007137164A3 Co-therapy for the treatment of epilepsy and related disorders |
| 01/17/2008 | WO2007137098A3 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 01/17/2008 | WO2007136830A3 Process for producing nanoparticles by spray drying |
| 01/17/2008 | WO2007136817A3 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 01/17/2008 | WO2007136743A3 Dothiepin and methods of using the same to treat sleep disorders |
| 01/17/2008 | WO2007136638A3 Prostaglandin transporter inhibitors |
| 01/17/2008 | WO2007136603A3 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/17/2008 | WO2007135574A8 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related method and compositions |
| 01/17/2008 | WO2007135406A3 New forms of active pharmaceutical ingredient |
| 01/17/2008 | WO2007135294A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 01/17/2008 | WO2007134259A3 Compounds and compositions as protein kinase inhibitors |
| 01/17/2008 | WO2007134086A3 Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
| 01/17/2008 | WO2007133673A3 Methods of treating a neurological disorder with creatine monohydrate |
| 01/17/2008 | WO2007131088A3 Oral rehydration compositions |
| 01/17/2008 | WO2007131021A3 Method of determining susceptibility to an antimicrobial agent |
| 01/17/2008 | WO2007131020A3 Constrained compounds as cgrp-receptor antagonists |
| 01/17/2008 | WO2007130626A3 Bivalent smac mimetics and the uses thereof |
| 01/17/2008 | WO2007130616A3 Polyamides for treating human papilloma virus |
| 01/17/2008 | WO2007130507A3 Acute pain medications based on fast acting diclofenac-opioid combinations |
| 01/17/2008 | WO2007127237A3 Methods of diagnosing and treating migraine |
| 01/17/2008 | WO2007125414A3 9a-substituted azalides for the tratment of malaria |
| 01/17/2008 | WO2007125405A3 Substituted 2-amino-fused heterocyclic compounds |
| 01/17/2008 | WO2007125173A3 Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease |
| 01/17/2008 | WO2007120925A3 Crystal forms of o-desmethylvenlafaxine |
| 01/17/2008 | WO2007117661A3 Drug microparticles |
| 01/17/2008 | WO2007114922A3 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 01/17/2008 | WO2007113202A8 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| 01/17/2008 | WO2007112000A3 Treatment of pain |
| 01/17/2008 | WO2007111880A3 Intranasal administration of ketamine to treat depression |
| 01/17/2008 | WO2007108004A3 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
| 01/17/2008 | WO2007105113A3 Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia |
| 01/17/2008 | WO2007101873A3 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer |
| 01/17/2008 | WO2007100617A3 Imidazole-based compounds, compositions comprising them and methods of their use |
| 01/17/2008 | WO2007098408A3 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 01/17/2008 | WO2007096777A3 Crystal form of besipirdine chlorhydrate, process preparation and use thereof |
| 01/17/2008 | WO2007093747A3 Use of tesaglitizar for preparing a pharmaceutical composition for treating skin disorders |
| 01/17/2008 | WO2007092936A3 Method to treat gastric lesions |
| 01/17/2008 | WO2007092343A3 Novel epoprostenol formulation and method of making thereof |
| 01/17/2008 | WO2007092312A3 Topical skin treating compositions |
| 01/17/2008 | WO2007089716A3 Use of aminopyrimidine compounds in the treatment of immune disorders |
| 01/17/2008 | WO2007087631A3 Cobalamin compositions for the treatment of cancer |